Akoya Biosciences, Inc.

NasdaqGS:AKYA 株式レポート

時価総額:US$109.1m

このページの翻訳は実験的なもので、現在開発中です。お待ちしております!

Akoya Biosciences マネジメント

マネジメント 基準チェック /34

Akoya Biosciences'の CEO はBrian McKelligonで、 Jul2017年に任命され、 の在任期間は 6.92年です。 の年間総報酬は$ 2.92Mで、 18.6%給与と81.4%のボーナス(会社の株式とオプションを含む)で構成されています。 は、会社の株式の0.075%を直接所有しており、その価値は$ 81.54K 。経営陣と取締役会の平均在任期間はそれぞれ3年と3.9年です。

主要情報

Brian McKelligon

最高経営責任者

US$2.9m

報酬総額

CEO給与比率18.6%
CEO在任期間6.9yrs
CEOの所有権0.08%
経営陣の平均在職期間3yrs
取締役会の平均在任期間3.9yrs

経営陣の近況

We Think Shareholders Are Less Likely To Approve A Large Pay Rise For Akoya Biosciences, Inc.'s (NASDAQ:AKYA) CEO For Now

May 29
We Think Shareholders Are Less Likely To Approve A Large Pay Rise For Akoya Biosciences, Inc.'s (NASDAQ:AKYA) CEO For Now

Recent updates

We Think Shareholders Are Less Likely To Approve A Large Pay Rise For Akoya Biosciences, Inc.'s (NASDAQ:AKYA) CEO For Now

May 29
We Think Shareholders Are Less Likely To Approve A Large Pay Rise For Akoya Biosciences, Inc.'s (NASDAQ:AKYA) CEO For Now

Investors Continue Waiting On Sidelines For Akoya Biosciences, Inc. (NASDAQ:AKYA)

May 10
Investors Continue Waiting On Sidelines For Akoya Biosciences, Inc. (NASDAQ:AKYA)

Is Akoya Biosciences (NASDAQ:AKYA) Weighed On By Its Debt Load?

Feb 28
Is Akoya Biosciences (NASDAQ:AKYA) Weighed On By Its Debt Load?

Investors Still Aren't Entirely Convinced By Akoya Biosciences, Inc.'s (NASDAQ:AKYA) Revenues Despite 31% Price Jump

Nov 25
Investors Still Aren't Entirely Convinced By Akoya Biosciences, Inc.'s (NASDAQ:AKYA) Revenues Despite 31% Price Jump

Akoya Biosciences Seeks Growth Despite Higher Operating Losses

May 30

Akoya Biosciences, Inc. (NASDAQ:AKYA) Just Reported First-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?

May 11
Akoya Biosciences, Inc. (NASDAQ:AKYA) Just Reported First-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?

Akoya Biosciences and AstraZeneca ink collaboration agreement

Jun 04

CEO報酬分析

Akoya Biosciences の収益と比較して、Brian McKelligon の報酬はどのように変化したか?
日付総報酬給与会社業績
Mar 31 2024n/an/a

-US$68m

Dec 31 2023US$3mUS$543k

-US$63m

Sep 30 2023n/an/a

-US$71m

Jun 30 2023n/an/a

-US$76m

Mar 31 2023n/an/a

-US$73m

Dec 31 2022US$3mUS$518k

-US$71m

Sep 30 2022n/an/a

-US$69m

Jun 30 2022n/an/a

-US$63m

Mar 31 2022n/an/a

-US$51m

Dec 31 2021US$2mUS$393k

-US$44m

Sep 30 2021n/an/a

-US$34m

Jun 30 2021n/an/a

-US$28m

Mar 31 2021n/an/a

-US$28m

Dec 31 2020US$516kUS$350k

-US$22m

Dec 31 2019US$484kUS$333k

-US$18m

報酬と市場: Brianの 総報酬 ($USD 2.92M ) は、 US市場 ($USD 667.63K ) の同規模の企業の平均を上回っています。

報酬と収益: Brianの報酬は、過去 1 年間の会社の業績と一致しています。


CEO(最高経営責任者

Brian McKelligon (55 yo)

6.9yrs

在職期間

US$2,919,599

報酬

Mr. Brian McKelligon has been Chief Executive Officer and Director at Akoya Biosciences, Inc. since July 2017 and also serves as its President. Prior to joining Akoya, he led corporate and business develop...


リーダーシップ・チーム

名称ポジション在職期間報酬所有権
Brian McKelligon
President6.9yrsUS$2.92m0.075%
$ 82.3k
John Ek
CFO, Principal Financial Officer & Principal Accounting Officer1.3yrsUS$2.37m0.093%
$ 101.1k
Frederic Pla
Chief Operating Officer3.3yrsUS$1.21m0.061%
$ 66.9k
Priyam Shah
Senior Director of Business Development & Investor Relations Strategyno dataデータなしデータなし
Jennifer Kamocsay
General Counsel1.3yrsデータなし0.012%
$ 13.5k
Niro Ramachandran
Chief Business Officer3.8yrsUS$365.22k0.29%
$ 320.0k
Pascal Bamford
Senior Vice President2.7yrsデータなしデータなし
Rob Hart
Secretaryno dataデータなしデータなし

3.0yrs

平均在職期間

53yo

平均年齢

経験豊富な経営陣: AKYAの経営陣は 経験豊富 であると考えられます ( 3年の平均在職年数)。


取締役

名称ポジション在職期間報酬所有権
Brian McKelligon
President6.9yrsUS$2.92m0.075%
$ 82.3k
Robert Shepler
Independent Chairman8.6yrsUS$251.66k0.75%
$ 816.8k
Myla Lai-Goldman
Independent Director2.8yrsUS$237.50k0.041%
$ 44.2k
Thomas Schnettler
Independent Director4.8yrsUS$220.00k0%
$ 0
Thomas Raffin
Director8.6yrsUS$210.00k0.48%
$ 518.4k
Matthew Winkler
Independent Director6.9yrsUS$232.50k1.99%
$ 2.2m
James Allison
Member of Scientific Advisory Boardless than a yearデータなしデータなし
Scott Mendel
Independent Director3yrsUS$250.00k0.058%
$ 63.0k
Padmanee Sharma
Member of Scientific Advisory Boardless than a yearデータなしデータなし
Garry Nolan
Chair of the Scientific Advisory Boardless than a yearUS$220.00k1.25%
$ 1.4m

3.9yrs

平均在職期間

66yo

平均年齢

経験豊富なボード: AKYAの 取締役会経験豊富 であると考えられます ( 3.9年の平均在任期間)。